Company

Aditum Bio

Biotechnology Research 1111 Broadway 52 employees

Employees: 52
Contacts: 4
Emails: 4
Phones: 2

aditumbio.com LinkedIn

Aditum Bio Overview

Headquarters: 1111 Broadway
Website: aditumbio.com
Industry: Biotechnology Research
Employees: 52
Founded: 2019
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Aditum Bio

Aditum is the Latin word for "access," and our mission is to give patients access to medicines that may not otherwise be developed. Aditum Bio is a new model of biotech venture capital uniquely positioned to rapidly translate scientific discoveries into innovative new medicines. Aditum Bio brings together unmatched scientific and domain expertise, combined with operational capabilities. Our agile operating model enables rapid company formation, planning and execution for a new model of drug development . We target clinic-ready therapies to help underserved patient populations, rapidly forming companies and staffing them with medical and scientific experts. Launched in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research, Dr. Mark Fishman, Aditum Bio currently manages a broad portfolio of clinical stage companies. For more information, please visit www.aditumbio.com.

Aditum Bio Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

Aditum Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Ramsey Johnson	Clinical and Regulatory Operations Professional with Over 25 Years of Experience.	Greater Boston, United States	Email Phone
Kevin Li	VP of Operations and Program Management, Tempero Bio	Greater Boston, United States	Email
Neeta Kulkarni	Associate Director, Project Management at Aditum Bio	San Francisco Bay Area, United States	Email
Susie Phillips	Head of Office Operations/senior Executive Assistant to the Co-founder and Managing Director	Oakland, California, United States	Email Phone